> top > projects > sonoma > docs > PubMed:19917135 > annotations
sonoma  

PubMed:19917135 JSONTXT 30 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T0 0-8 POSREG denotes Elevated
T1 9-19 MPA denotes expression
T2 23-26 GENE denotes p53
T3 27-43 POSREG denotes gain-of-function
T4 53-58 VAR denotes R175H
T5 62-80 DISEASE denotes endometrial cancer
T6 91-99 POSREG denotes increase
T7 104-123 CPA denotes invasive phenotypes
T8 127-137 POSREG denotes activation
T9 145-166 PATHWAY denotes EGFR/PI3K/AKT pathway
T10 180-183 GENE denotes p53
T11 205-212 VAR denotes mutated
T12 238-251 DISEASE denotes human cancers
T13 272-276 NEGREG denotes loss
T14 280-306 MPA denotes tumor suppression function
T15 311-319 POSREG denotes exertion
T16 323-340 NEGREG denotes dominant-negative
T17 395-398 GENE denotes p53
T18 399-406 VAR denotes mutants
T19 411-415 POSREG denotes gain
T20 422-441 MPA denotes oncogenic functions
T21 443-459 POSREG denotes gain-of-function
T22 461-464 POSREG denotes GOF
T23 480-488 REG denotes regulate
T24 496-507 CPA denotes development
T25 512-523 CPA denotes progression
T26 534-552 DISEASE denotes endometrial cancer
T27 554-557 GENE denotes p53
T28 558-566 VAR denotes mutation
T29 581-591 REG denotes associated
T30 608-630 DISEASE denotes nonendometrioid cancer
T31 659-662 GENE denotes p53
T32 663-670 VAR denotes mutants
T33 671-682 REG denotes contributed
T34 686-704 DISEASE denotes endometrial cancer
T35 705-716 CPA denotes progression
T36 729-732 POSREG denotes GOF
T37 769-781 REG denotes relationship
T38 790-800 MPA denotes expression
T39 804-807 GENE denotes p53
T40 808-811 POSREG denotes GOF
T41 812-820 VAR denotes mutation
T42 822-831 VAR denotes p53-R175H
T43 837-855 CPA denotes invasive potential
T44 865-883 DISEASE denotes endometrial cancer
T45 925-938 POSREG denotes up-regulation
T46 943-958 NEGREG denotes down-regulation
T47 962-971 VAR denotes p53-R175H
T48 988-996 POSREG denotes inducing
T49 997-1006 VAR denotes p53-R175H
T50 1028-1039 NEGREG denotes suppressing
T51 1044-1047 GENE denotes p53
T52 1100-1106 POSREG denotes forced
T53 1107-1122 POSREG denotes over-expression
T54 1126-1135 VAR denotes p53-R175H
T55 1150-1158 POSREG denotes promoted
T56 1164-1173 CPA denotes migration
T57 1178-1186 CPA denotes invasion
T58 1192-1199 POSREG denotes induced
T59 1200-1210 POSREG denotes activation
T60 1218-1306 PATHWAY denotes epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway
T61 1320-1331 NEGREG denotes suppression
T62 1382-1391 NEGREG denotes inhibited
T63 1397-1406 CPA denotes migration
T64 1411-1419 CPA denotes invasion
T65 1425-1433 REG denotes resulted
T66 1437-1448 NEGREG denotes attenuation
T67 1452-1473 PATHWAY denotes EGFR/PI3K/AKT pathway
T68 1531-1539 POSREG denotes elevated
T69 1540-1550 MPA denotes expression
T70 1581-1597 POSREG denotes gain-of-function
T71 1598-1606 MPA denotes activity
T72 1610-1618 POSREG denotes activate
T73 1623-1644 PATHWAY denotes EGFR/PI3K/AKT pathway
T74 1658-1668 REG denotes contribute
T75 1676-1694 CPA denotes invasive phenotype
T76 1698-1716 DISEASE denotes endometrial cancer
R0 T0 T3 CauseOf Elevated,gain-of-function
R1 T0 T6 CauseOf Elevated,increase
R10 T5 T3 ThemeOf endometrial cancer,gain-of-function
R11 T5 T4 ThemeOf endometrial cancer,R175H
R12 T8 T6 CauseOf activation,increase
R13 T7 T6 ThemeOf invasive phenotypes,increase
R14 T9 T8 ThemeOf EGFR/PI3K/AKT pathway,activation
R15 T10 T11 ThemeOf p53,mutated
R16 T12 T11 ThemeOf human cancers,mutated
R17 T11 T13 CauseOf mutated,loss
R18 T11 T15 CauseOf mutated,exertion
R19 T14 T13 ThemeOf tumor suppression function,loss
R2 T0 T8 CauseOf Elevated,activation
R20 T17 T18 ThemeOf p53,mutants
R21 T18 T13 CauseOf mutants,loss
R22 T18 T15 CauseOf mutants,exertion
R23 T18 T19 CauseOf mutants,gain
R24 T18 T21 CauseOf mutants,gain-of-function
R25 T18 T22 CauseOf mutants,GOF
R26 T18 T23 CauseOf mutants,regulate
R27 T20 T19 ThemeOf oncogenic functions,gain
R28 T24 T23 ThemeOf development,regulate
R29 T25 T23 ThemeOf progression,regulate
R3 T1 T0 ThemeOf expression,Elevated
R30 T26 T29 ThemeOf endometrial cancer,associated
R31 T27 T28 ThemeOf p53,mutation
R32 T28 T29 CauseOf mutation,associated
R33 T30 T29 ThemeOf nonendometrioid cancer,associated
R34 T31 T32 ThemeOf p53,mutants
R35 T32 T33 CauseOf mutants,contributed
R36 T32 T35 CauseOf mutants,progression
R37 T32 T36 CauseOf mutants,GOF
R38 T34 T33 ThemeOf endometrial cancer,contributed
R39 T34 T35 ThemeOf endometrial cancer,progression
R4 T2 T1 ThemeOf p53,expression
R40 T34 T36 ThemeOf endometrial cancer,GOF
R41 T35 T33 ThemeOf progression,contributed
R42 T35 T36 ThemeOf progression,GOF
R43 T38 T37 ThemeOf expression,relationship
R44 T38 T40 ThemeOf expression,GOF
R45 T39 T37 ThemeOf p53,relationship
R46 T39 T38 ThemeOf p53,expression
R47 T39 T41 ThemeOf p53,mutation
R48 T41 T40 CauseOf mutation,GOF
R49 T42 T38 ThemeOf p53-R175H,expression
R5 T4 T3 CauseOf R175H,gain-of-function
R50 T42 T41 ThemeOf p53-R175H,mutation
R51 T44 T37 ThemeOf endometrial cancer,relationship
R52 T44 T38 ThemeOf endometrial cancer,expression
R53 T44 T40 ThemeOf endometrial cancer,GOF
R54 T44 T43 ThemeOf endometrial cancer,invasive potential
R55 T44 T45 ThemeOf endometrial cancer,up-regulation
R56 T47 T46 ThemeOf p53-R175H,down-regulation
R57 T50 T48 CauseOf suppressing,inducing
R58 T51 T50 ThemeOf p53,suppressing
R59 T52 T55 CauseOf forced,promoted
R6 T4 T6 CauseOf R175H,increase
R60 T52 T58 CauseOf forced,induced
R61 T53 T55 CauseOf over-expression,promoted
R62 T53 T58 CauseOf over-expression,induced
R63 T54 T53 ThemeOf p53-R175H,over-expression
R64 T54 T58 CauseOf p53-R175H,induced
R65 T56 T55 ThemeOf migration,promoted
R66 T57 T55 ThemeOf invasion,promoted
R67 T60 T58 ThemeOf epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway,induced
R68 T60 T59 ThemeOf epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway,activation
R69 T61 T62 CauseOf suppression,inhibited
R7 T4 T8 CauseOf R175H,activation
R70 T61 T65 CauseOf suppression,resulted
R71 T61 T66 CauseOf suppression,attenuation
R72 T63 T62 ThemeOf migration,inhibited
R73 T64 T62 ThemeOf invasion,inhibited
R74 T67 T66 ThemeOf EGFR/PI3K/AKT pathway,attenuation
R75 T68 T70 CauseOf elevated,gain-of-function
R76 T68 T72 CauseOf elevated,activate
R77 T68 T74 CauseOf elevated,contribute
R78 T69 T68 ThemeOf expression,elevated
R79 T73 T72 ThemeOf EGFR/PI3K/AKT pathway,activate
R8 T5 T0 ThemeOf endometrial cancer,Elevated
R80 T75 T74 ThemeOf invasive phenotype,contribute
R81 T76 T74 ThemeOf endometrial cancer,contribute
R82 T76 T75 ThemeOf endometrial cancer,invasive phenotype
R9 T5 T1 ThemeOf endometrial cancer,expression